International orthopaedic trials: global reach for a global burden of disease

Journal article

Musculoskeletal diseases are having a growing impact worldwide. It is therefore crucial to have an evidence base to most effectively and efficiently implement future health services across different healthcare systems. International trials are an opportunity to address these challenges and have many potential benefits. They are, however, complex to set up and deliver, which may impact on the efficient and timely delivery of a project. There are a number of models of how international trials are currently being delivered across a range of orthopaedic patient populations, which are discussed here. The examples given highlight that the key to overcoming these challenges is the development of trusted and equal partnerships with collaborators in each country. International trials have the potential to address a global burden of disease, and in turn optimize the benefit to patients in the collaborating countries and those with similar health services and care systems.

Authors: Costa, ML; Brealey, S; Perry, D

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: British Editorial Society of Bone and Joint Surgery
• Journal: Bone and Joint Journal
• Volume: 105-B
• Issue: 7
• Pages: 719-722
• Publication date: 2023-07-01
• Acceptance date: 2023-04-04
• DOI: 10.1302/0301-620X.105B7.BJJ-2023-0070
• EISSN: 2049-4408
• ISSN: 2049-4394
• Language: English
• Keywords: tibial fractures; musculoskeletal diseases; medial epicondyle fractures; fracture fixation; orthopaedics; international; physiotherapists; clinicians; randomized controlled trials; orthogeriatricians; locking plate; FFR; hip fracture